JOINT FILING STATEMENTJoint Filing Statement • May 5th, 2022 • Hothum Mathias • Pharmaceutical preparations
Contract Type FiledMay 5th, 2022 Company IndustryIn accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common shares of CureVac N.V. and further agree that this Joint Filing Agreement be included as an exhibit to such joint filing.